Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Deletion of 9p drives B-ALL through heterozygous inactivation of Pax5 and Cd72 in preleukemic cells

  • Ruiz-Corzo, Belén
  • Casado-García, Ana
  • Oak, Ninad
  • Somoza-Cotillas, Paula
  • López-Álvarez de Neyra, Andrea
  • Martínez-Cano, Jorge
  • Pérez-Pons, Alba
  • Sánchez, Elena G.
  • Blanco, Oscar
  • Blanco, Oscar
  • Alonso-López, Diego
  • De Las Rivas, Javier
  • Riesco, Susana
  • Prieto-Matos, Pablo
  • García Criado, Francisco Javier
  • García Cenador, María Begoña
  • Orfao, Alberto
  • Ramírez-Orellana, Manuel
  • Cobaleda, César
  • Vicente-Dueñas, Carolina
  • Nichols, Kim E.
  • Sánchez-García, Isidro
The contribution of 9p deletion to B cell acute lymphoblastic leukemia (B-ALL) has remained elusive since its discovery more than 40 years ago. Here we show that loss of CD72 is recurrent in B-ALL cases containing PAX5 deletions, and that Cd72 haploinsufficiency drives B-ALL development in Pax5+/- mice. Mechanistically, Cd72+/-;Pax5+/- precursor B cells exhibited an inflammatory transcriptional profile characterized by a decrease in Myd88 expression, a finding that aligns with our previous studies of B-ALL development in Pax5+/- mice following exposure to immune stressors. These combined genomic analyses and functional models provide compelling evidence that co-deletion of 2 contiguous genes, Pax5 and Cd72, drives B cell leukemogenesis., MICIU/AEI/ 10.13039/501100011033 and ERDF/EU grants PID2021-122185OB-I00 and PID2024-155590OB-I00 (to ISG). Junta de Castilla y León grants UIC-017, CSI144P20, and CSI016P23 (to ISG). Fundacion Unoentrecienmil CUNINA2 project (to ISG). Fundación Científica de la Asociación Española contra el Cáncer (TRNSC247893SÁNC) (to ISG). Instituto de Salud Carlos III (ISCIII) (AC24/00021) (to ISG). Fundación Científica de la Asociación Española contra el Cáncer grant PRYCO211305SANC (to CC, MR, and ISG). “La Caixa” Foundation under the project code LCF/PR/HR25/52450048 (to CC, MR, and ISG). TRANSCAN2023-1858-066 – REACTION Project (to MR and ISG). Research at C. Cobaleda’s laboratory was partially supported by Grant PID2021-122787OB-I00 funded by MICIU/AEI/ 10.13039/501100011033 and ERDF/EU grant PID2021-122787OB-I00 (to CC). “Fundación Síndrome de Wolf-Hirschhorn o 4p-” research contract (to CC). “Fundación Ramón Areces” and “Banco de Santander” institutional grants to the Centro de Biología Molecular. Instituto de Salud Carlos III (ISCIII) project PI22/00379 (to CVD). American Lebanese Syrian Associated Charities (ALSAC) (to KEN). National Cancer Institute/NIH grant R01CA241452 (to KEN). National Institute of Allergy and Infectious Diseases Histiocytosis Association Cures within Reach grant R21AI113490 (to KEN). Asociación Pablo Ugarte (to MR). FSE-Conserjería de Educación de la Junta de Castilla y León 2019 (ESF, European Social Fund) fellowship CSI067-18 (to ACG). Juan de la Cierva 2022 grant JDC2022-049078-I (to ACG). FSE-Conserjería de Educación de la Junta de Castilla y León 2022 (ESF, European Social Fund) fellowship CSI002-22 (to BRC). Ayuda para Contratos predoctorales para la formación de doctores (PRE2022-103628) (to ALAN). Universidad Autónoma de Madrid predoctoral fellowship FPI-UAM 2019 (to JMC).